CCUN Helps FDA Launch Clinical Trials of New MM Treatments

CRIS Against Cancer Donates Over $3 Million to CCUN Cancer Research

The foundation supports the fight against melanoma, multiple myeloma, lung, ovarian and kidney cancer. + read more

Spain needs clinical research network to be a leader in Europe

Clinical researchers, the pharmaceutical industry and the Spanish Agency for Medicines and Health Products came together at a meeting organised by CCUN to maintain the country’s leadership and attractiveness in promoting Phase I cancer research. + more

Dagger Cells: Beyond CAR-T in Multiple Myeloma

According to a study conducted by the CNIO and the University Hospital on October 12, a new immunotherapy against multiple myeloma shows greater efficacy in the laboratory than the already used CAR-T. + read more

The European Union, with the support of CCUN, promotes lung cancer screening among women

The SOLACE project is launching an information campaign to ensure that women benefit from early detection of diseases that have tripled in the last two decades. + read more

Getting Closer to Preventing Symptomatic Multiple Myeloma

Today it is known that a patient with multiple myeloma does not have all the clinical manifestations of the disease, but rather has a precancerous phase in which one or another marker can be detected. + read more

CCUN, VHIO and Princess Margaret join forces in the fight against pancreatic cancer

AstraZeneca is funding a $2 million research project led by the Oncology Center of the University Hospital of Navarra that will seek to understand the changes induced by chemotherapy in the microenvironment of pancreatic tumors. + read more